KLRK1 and Miyoshi myopathy: Taking into account the prominent role of miR-17-92 cluster in MM [10, 39–41] and the already reported capability of miR-17 family to modulate the expression of NKG2D ligands [42–44], the effects of trabectedin on the expression levels of miR-17 and miR-20a (the two miRNAs of the miR-17-92 cluster belonging to the miR-17 family) has been evaluated.